Targeting antigens to dendritic cell receptors for vaccine development.
Dendritic cells (DCs) are highly specialized antigen presenting cells of the immune system which play a key role in regulating immune responses. Depending on the method of antigen delivery, DCs stimulate immune responses or induce tolerance. As a consequence of the dual function of DCs, DCs are studied in the context of immunotherapy for both cancer and autoimmune diseases. In vaccine development, a major aim is to induce strong, specific T-cell responses. This is achieved by targeting antigen to cell surface molecules on DCs that efficiently channel the antigen into endocytic compartments for loading onto MHC molecules and stimulation of T-cell responses. The most attractive cell surface receptors, expressed on DCs used as targets for antigen delivery for cancer and other diseases, are discussed.
VA Consulting Services, Melbourne, VIC, Australia ; College of Health and Biomedicine, Victoria University, VIC, Australia.
Vasso
V
Apostolopoulos
Theresia
T
Thalhammer
Andreas G
AG
Tzakos
Lily
L
Stojanovska